Vivozon Healthcare Inc (082800) — Cash Flow-to-Debt Ratio
Vivozon Healthcare Inc (082800) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of ₩-5.41 Billion could theoretically repay 0% of its total liabilities (₩73.01 Billion) in one year. See Vivozon Healthcare Inc (082800) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vivozon Healthcare Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Vivozon Healthcare Inc across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Vivozon Healthcare Inc.
Annual Cash Flow-to-Debt Ratio for Vivozon Healthcare Inc (2014–2025)
Year-by-year debt coverage analysis for Vivozon Healthcare Inc. Check cash flow quality index of Vivozon Healthcare Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | ₩-6.87 Billion | ₩92.82 Billion | ▼ -200.7% |
| 2024 | 0.07x | ₩5.73 Billion | ₩78.02 Billion | ▲ +70.8% |
| 2023 | 0.04x | ₩2.99 Billion | ₩69.58 Billion | ▲ +205.1% |
| 2022 | -0.04x | ₩-3.32 Billion | ₩81.24 Billion | ▲ +74.4% |
| 2021 | -0.16x | ₩-17.50 Billion | ₩109.35 Billion | ▼ -585.6% |
| 2020 | 0.03x | ₩4.62 Billion | ₩140.36 Billion | ▲ +147.1% |
| 2019 | -0.07x | ₩-3.89 Billion | ₩55.66 Billion | ▲ +50.9% |
| 2018 | -0.14x | ₩-4.59 Billion | ₩32.21 Billion | ▲ +37.0% |
| 2017 | -0.23x | ₩-4.59 Billion | ₩20.31 Billion | ▼ -174.0% |
| 2016 | 0.31x | ₩5.87 Billion | ₩19.22 Billion | ▲ +163.8% |
| 2015 | 0.12x | ₩2.78 Billion | ₩24.05 Billion | ▼ -24.9% |
| 2014 | 0.15x | ₩3.03 Billion | ₩19.64 Billion | — |